Sable · Question
What is the difference between Cartalax and IGF-1 LR3?
Cartalax is a synthetic tripeptide from the Khavinson short-peptide series studied in cartilage-cell (chondrocyte) culture research (peptide, MW about 333.29 g/mol).
Research use only. Not for human consumption. No health claims.
Last verified 2026-10-10
What is the difference between Cartalax and IGF-1 LR3?
Cartalax is a synthetic tripeptide from the Khavinson short-peptide series studied in cartilage-cell (chondrocyte) culture research (peptide, MW about 333.29 g/mol).
Which is heavier, Cartalax or IGF-1 LR3?
Cartalax has a molecular weight of about 333.29 g/mol and IGF-1 LR3 about 9111 g/mol (PubChem), so IGF-1 LR3 is heavier by 8,777.7 g/mol, a ratio of 27.34. This means 1 mg of Cartalax contains 3,000.4 nmol versus 109.8 nmol for IGF-1 LR3.
How many mg of IGF-1 LR3 are equimolar to 1 mg of Cartalax?
1 mg of Cartalax (MW 333.29) is 3,000.4 nmol. The same number of moles of IGF-1 LR3 (MW 9111) weighs 27.337 mg. Equimolar comparisons matter when testing two compounds side by side in the same assay.
A 10 mg vial of Cartalax equals how many mg of IGF-1 LR3 in moles?
10 mg of Cartalax (MW 333.29) is 30.004 µmol. The same amount of IGF-1 LR3 (MW 9111) would weigh 273.4 mg. This equimolar conversion lets two compounds be compared at matched molar amounts in the same experiment.
A 20 mg vial of Cartalax equals how many mg of IGF-1 LR3 in moles?
20 mg of Cartalax (MW 333.29) is 60.008 µmol. The same amount of IGF-1 LR3 (MW 9111) would weigh 546.7 mg. This equimolar conversion lets two compounds be compared at matched molar amounts in the same experiment.
A 0.1 mg vial of IGF-1 LR3 equals how many mg of Cartalax in moles?
0.1 mg of IGF-1 LR3 (MW 9111) is 0.01098 µmol. The same amount of Cartalax (MW 333.29) would weigh 0.003658 mg. This equimolar conversion lets two compounds be compared at matched molar amounts in the same experiment.
A 1 mg vial of IGF-1 LR3 equals how many mg of Cartalax in moles?
1 mg of IGF-1 LR3 (MW 9111) is 0.1098 µmol. The same amount of Cartalax (MW 333.29) would weigh 0.03658 mg. This equimolar conversion lets two compounds be compared at matched molar amounts in the same experiment.
A CoA for every lot; each vial carries a printed lot number that matches it. Ask with the lot number and we send it.
Cite this
Research use only. Not for consumption. No health claims.
Plain
Sable Peptides. (2026). What is the difference between Cartalax and IGF-1 LR3?. UK Research Peptide Reference. Retrieved 11 October 2026, from https://www.sablepeptides.co.uk/questions/compare/cartalax-vs-igf-1-lr3/#sqa-041258
APA
Sable Peptides. (2026, October 11). *What is the difference between Cartalax and IGF-1 LR3?*. UK Research Peptide Reference. https://www.sablepeptides.co.uk/questions/compare/cartalax-vs-igf-1-lr3/#sqa-041258
BibTeX
@misc{sable_#sqa-041258_2026,
author = {{Sable Peptides}},
title = {{What is the difference between Cartalax and IGF-1 LR3?}},
year = {2026},
howpublished = {\url{https://www.sablepeptides.co.uk/questions/compare/cartalax-vs-igf-1-lr3/#sqa-041258}},
note = {Accessed 11 October 2026. CC BY 4.0}
}Badge
<a href="https://www.sablepeptides.co.uk/ref"><img src="https://www.sablepeptides.co.uk/badge/ref.svg" alt="Data: UK Research Peptide Reference — Sable Peptides" width="220" height="40"></a>
Date modified: 2026-10-10